CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
![Medical research, technology, innovation, AI-GettyImages-2226144959]( "The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity")
The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data IntegrityDiscover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry.
-
![Cybersecurity, digital connection, digital safety-GettyImages-2123163641]( "Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them")
Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address ThemExplore some of the common pitfalls witnessed in healthcare environments, as well as guidance for implementing a penetration testing program.
ECOA RESOURCES
-
![GettyImages-1215304804_placebo]( "Placebo Response In Clinical Trials: Challenges And Mitigation Strategies")
Placebo response can impact clinical trial outcomes. Signant Health offers solutions such as eCOA, and tailored training to mitigate these effects and ensure reliable, accurate results.
-
![gettyimages-1374251769-170667a]( "Strong eCOA Provider And Linguistic Validation Expert Partner For Success")
Explore the creation and implementation of the electronic versions of COAs (eCOAs) on a high priority study with a new client.
-
The shift from reporting on paper to reporting electronically has been happening for years, however, the transition hasn’t always been elegant. Explore how the pandemic has played a role in accelerating the shift to eCOA/ePRO.
ECONSENT RESOURCES
-
![Global network concept GettyImages-913629624]( "Going Global With eConsent")
Scott Askin paints the picture of why Novartis, determined to improve the patient experience, has begun to deploy eConsent, and what they’ve learned along the way.
-
![webinar__econsent_a_flexible_approach__final]( "The Revival Of Electronic Informed Consent")
The clinical research industry has been reluctant to adopt eConsent for several reasons. Unearth how the industry should continue exploring and implementing digital technologies in earnest in the future.
-
![total_consent_adoption_feb_22_presentation_rev]( "Everything You Need To Know About Adopting eConsent Across Large Pharma Organizations")
Did you know that the average cost for a delayed trial is between $600,000 and $8 million per day? Discover how electronic consent management technology is helping sponsors, CROs, and sites.
EPRO RESOURCES
-
The shift from reporting on paper to reporting electronically has been happening for years, however, the transition hasn’t always been elegant. Explore how the pandemic has played a role in accelerating the shift to eCOA/ePRO.
-
![GettyImages-1350880819 epro]( "Measuring The True Patient Experience")
Utilizing the insights covered in this article can inform the design and implementation of cancer trials, ultimately contributing to improved patient care and treatment outcomes.
-
![Patient Reported Outcome ePRO]( "How To Overcome The Problem Of The Early ePRO Oversell")
In this blog, explore how the approach to PROs needs to be reconsidered, given increasing regulations and trial scrutiny, the clinical need for patient-reported outcomes, and the ability to drive costs down and move off paper.
